首页 正文

Pharmaceutics. 2024 Dec 16;16(12):1602. doi: 10.3390/pharmaceutics16121602 Q15.52025

Drug-Phospholipid Co-Amorphous Formulations: The Role of Preparation Methods and Phospholipid Selection

药物-磷脂共无定形单元剂型:制备方法和磷脂选择的作用 翻译改进

Keyoomars Khorami  1, Sam Darestani Farahani  1, Anette Müllertz  1, Thomas Rades  1

作者单位 +展开

作者单位

  • 1 Department of Pharmacy, Faculty of Health and Medical Science, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
  • DOI: 10.3390/pharmaceutics16121602 PMID: 39771580

    摘要 Ai翻译

    Background/Objectives: This study aims to broaden the knowledge on co-amorphous phospholipid systems (CAPSs) by exploring the formation of CAPSs with a broader range of poorly water-soluble drugs, celecoxib (CCX), furosemide (FUR), nilotinib (NIL), and ritonavir (RIT), combined with amphiphilic phospholipids (PLs), including soybean phosphatidylcholine (SPC), hydrogenated phosphatidylcholine (HPC), and mono-acyl phosphatidylcholine (MAPC). Methods: The CAP... ...点击完成人机验证后继续浏览
    Copyright © Pharmaceutics. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Pharmaceutics

    缩写:PHARMACEUTICS

    ISSN:N/A

    e-ISSN:1999-4923

    IF/分区:5.5/Q1

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Drug-Phospholipid Co-Amorphous Formulations: The Role of Preparation Methods and Phospholipid Selection